Herein, using a two-sample MR approach, we demonstrated that increased expression levels of CD16–CD56+ on NK cells and HLA-DR+ NK cells were causally associated with a decreased risk of ALS, indicating that these two subsets of NK cells are protective factors against ALS. Here, NCAM1 is linked to amyotrophic lateral sclerosis.